Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

Rservlogix large

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free

Reply New Message

Back To Forum List View

Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

4

Mar 24, 2020 12:59PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

8

Mar 24, 2020 02:05PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

4

Mar 24, 2020 02:41PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

7

Mar 24, 2020 02:53PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

6

Mar 24, 2020 03:54PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

1

Mar 24, 2020 04:10PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

2

Mar 24, 2020 04:20PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

5

Mar 24, 2020 04:33PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

1

Mar 24, 2020 04:37PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

4

Mar 24, 2020 05:00PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 24, 2020 05:40PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

1

Mar 24, 2020 05:41PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

5

Mar 24, 2020 05:56PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

6

Mar 24, 2020 06:08PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

6

Mar 26, 2020 05:37AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

6

Mar 26, 2020 08:47AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 26, 2020 09:31AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

5

Mar 26, 2020 09:58AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

9

Mar 26, 2020 01:10PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

4

Mar 26, 2020 01:34PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

7

Mar 26, 2020 01:37PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

8

Mar 26, 2020 02:36PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

6

Mar 26, 2020 02:53PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

6

Mar 26, 2020 02:55PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

5

Mar 26, 2020 03:12PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

2

Mar 26, 2020 03:39PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

2

Mar 26, 2020 03:45PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

4

Mar 26, 2020 04:11PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 26, 2020 05:55PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

5

Mar 26, 2020 06:08PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication - Derek Lowe

4

Mar 26, 2020 06:14PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 26, 2020 06:19PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

5

Mar 26, 2020 06:29PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

4

Mar 26, 2020 06:41PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 26, 2020 07:03PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

7

Mar 27, 2020 10:19AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

7

Mar 27, 2020 10:43AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

6

Mar 27, 2020 10:58AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 27, 2020 10:58AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

4

Mar 27, 2020 11:05AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

9

Mar 27, 2020 11:08AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 27, 2020 11:26AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 27, 2020 11:31AM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

1

Mar 27, 2020 11:51AM

cityslicker99

Rank: President [?]

Points: 1942 [?]

Votes: 24 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

in response to

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

by

posted on Mar 27, 2020 12:42PM

Log in to use the IP Check tool ^[?]

Unless they had reason to collect data on ACE conc and dose, they might not be sufficient. Ideally, you would need to look at several doses.

2 Recommendations

Loading...

Loading...

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

3

Mar 27, 2020 01:11PM

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

4

Mar 27, 2020 02:11PM

Reply New Message

Back To Forum List View

Share

Share

Share

Please to post a reply